Expression and significance of CGRP and ETRA in the basilar artery after subarachnoid hemorrhage in a rabbit model

Journal of Xi'an Jiaotong University (Medical Sciences)

Volumn 29, Issue 4, 2008, Pages 412-416

  Song, Jinning ^a   Zhang, Ming ^a   Liang, Qi ^a   Sui, Long ^a   Wang, Wenbo ^a   Xi, Lei ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Calcitonin gene related peptide; Cerebral vasospasm; Endothelin receptor A; Immunohistochemistry; Subarachnoid hemorrhage

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR A; EOSIN; HEMATOXYLIN; PARAFFIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; BASILAR ARTERY; BRAIN BLOOD VESSEL; BRAIN PERFUSION; BRAIN VASOSPASM; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; PUNCTURE; RABBIT; SUBARACHNOID HEMORRHAGE;

EID: 54049154330     PISSN: 16718259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dietrich HH, Dacey RG. Molecular keys to the problems of cerebral vasospasm [J]. Neurosurgery, 2000, 46(3):517-530.
2. Hansen J, Hoel N, Mingfang Z. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries [J]. Neurosurgery, 2003, 52(5):1188-1195.
3. Bucinskaite V, Brodda G, Stenfors C, et al. Increased concentrations of calcitonin gene-related peptide immunoreactivity in rat brain and peripheral tissue after ischacmia: correlation to flap survival [J]. Neuropetides, 1998, 32(2):179-183.
4. Ahmad I, Imaizumi S, Shimizu H, et al. Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage [J]. Acta Neurochir (wien), 1996, 138(10):1230-1240.
5. Inoue T, Shimizu H, Kaminuma T, et al. Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-releases tablet after subarachnoid hemorrhage in monkeys [J]. Neurosurgery, 1996, 39(5):984-990.
6. Lu LF, Fiscus RR. Nitric oxide donors enhance calcitonin gene-related peptide-induced elevations of cyclic AMP invascular smooth muscle cells [J]. Eur J Pharmacol, 1999, 376(3):307-314.
7. Rosenblum WI, Shimizu T, Nelson GH. Endothelium-dependent effects of substance P and calcitonin gene-related peptide on mouse pial arterioles [J]. Stroke, 1993, 24(7):1043-1047.
8. Holland JP, Sydserff SG, Taylor WS, et al. Calcitonin gene-related peptide reduces brain injury in a rat model of focal cerebral ischemia [J]. Stroke, 1994, 25(10):2055-2059.
9. Yanagisawa M, Kurihara H, Kiumra S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelia cells [J]. Nature, 1988, 332(6163): 411-415.
10. Ander M, You I, Edvinsson L, et al. Characterization of endothelin-A receptors in the cerebral circulation [J]. Neuroreport, 1993, 4(4):441-443.
11. Fernandze N, Monge I, Garcia-Villalon AI, et al. Endothelin-1 induced in vitro cerebral vasoconstriction is mediated by endothelin ETA receptors [J]. Eur J Pharmacol, 1995, 294(2-3):483-490.
12. Nilsson T, Cantera L, Adner M, et al. Presence of contractile endothelin-A and dilatory endothelia-B rceptors in human cerebral arteries [J]. Neurosurgery, 1997, 40(2):346-353.
13. Imaizumi S, Shimizu H, Ahmad I, et al. Effect of calcitonin gene-related peptide on delayed cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits [J]. Surg Neurol, 1996, 46(3):263-270.
14. Chinese source